Table 1 Demographics and population characteristics of teratoma and age-matched control groups.
From: Risk of epilepsy in gonadal teratoma: a nationwide population-based study
Control | Ovarian teratoma | p | Control | Testicular teratoma | p | |
|---|---|---|---|---|---|---|
Total (n) | 188,384 | 94,203 | 4628 | 2314 | ||
Age (years) | 40.99 ± 11.83 | 40.99 ± 11.83 | 41.68 ± 14.97 | 41.68 ± 14.97 | ||
Hypertension (HBP) | 31,181 (16.55) | 15,176 (16.11) | 0.0028 | 1176 ± 25.41 (25.41) | 594 (25.67) | 0.8152 |
Diabetes (DM) | 34,659 (18.45) | 17,420 (18.49) | 0.7920 | 1009 ± 21.8 (21.8) | 522 (22.56) | 0.4737 |
Dyslipidemia | 76,357 (40.53) | 38,744 (41.13) | 0.0024 | 1896 ± 40.97 (40.97) | 1032 (44.6) | 0.0039 |
Ischemic heart disease | 15,079 (8.0) | 7912 (8.40) | 0.0003 | 557 ± 12.04 (12.04) | 320 (13.83) | 0.0340 |
Malignancy | 16,253 (17.25) | 1187 (51.30) | ||||
Tumor resection | 23,770 (25.23) | 539 (23.29) |
